Pharma Journalist -

HemoShear Therapeutics, LLC announced an extension of its partnership with Takeda Pharmaceutical Company Limited to discover and develop additional novel therapeutics for liver…
Read More...

In just 3 weeks, the highly anticipated Pharmaceutical Microbiology East Coast conference and exhibition will take place in Boston, USA, on April 10 and 11, 2019. SMi Group are…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial…
Read More...

Merck and NGM Biopharmaceuticals announced that Merck has exercised its option to extend the research phase of the companies’ broad, strategic collaboration for an additional two-year…
Read More...

Alexion Pharmaceuticals and Affibody AB announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development,…
Read More...

The Mundipharma network of independent associated companies is pleased to launch the type-2 diabetes mellitus (T2DM) treatments Invokana (canagliflozin) and Vokanamet (canagliflozin,…
Read More...

WuXi Biologics announced that it has received EMA GMP certificates for the production of Trogarzo at its cGMP Drug Substance (DS) and Drug Product (DP) manufacturing facilities in Wuxi…
Read More...

EastGate Biotech Corp., a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes,…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam),…
Read More...

Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved ZULRESSOTM (brexanolone) injection for the treatment of postpartum depression (PPD). ZULRESSO…
Read More...